FZD6 and prostate carcinoma: We knocked down FZD6 in multiple prostate cancer cell lines and prostate cancer patient-derived xenograft models and demonstrated that knocking down FZD6 suppresses prostate cancer growth in vitro and in vivo and attenuates the DNA damage repair process.